| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI00347A005 |
| P698 | PubMed publication ID | 3004558 |
| P2093 | author name string | S J Lippard | |
| A Varshavsky | |||
| M J Solomon | |||
| R B Ciccarelli | |||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7533-7540 | |
| P577 | publication date | 1985-12-01 | |
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication | |
| P478 | volume | 24 |
| Q42390503 | 2'-deoxy-5-azacytidine increases binding of cisplatin to DNA by a mechanism independent of DNA hypomethylation |
| Q69585954 | A high melting cis-[Pt(NH3)2[d(GpG)]]adduct of a decanucleotide duplex |
| Q36785185 | A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells |
| Q37296780 | An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts |
| Q29617899 | Cellular processing of platinum anticancer drugs |
| Q69638248 | Chromosome-damaging activity of a ruthenium radiosensitizer, RuCl2 (DMSO)2 (4-nitroimidazole)2, in Chinese hamster ovary cells in vitro |
| Q39315869 | Cisplatin and ultra-violet-C synergistically down-regulate receptor tyrosine kinases in human colorectal cancer cells |
| Q46793147 | Cisplatin induced cell killing and chromosomal aberrations in CHO cells: treated during G1 or S phase |
| Q28535275 | Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions |
| Q47983202 | Cisplatin resistance in cyclic AMP-dependent protein kinase mutants |
| Q34348474 | Cisplatin: from DNA damage to cancer chemotherapy. |
| Q39715308 | DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2]. |
| Q34725611 | DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. |
| Q38348382 | DNA-protein cross-linking by trans-[PtCl2(E-iminoether)2]. A concept for activation of the trans geometry in platinum antitumor complexes |
| Q92154985 | Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression |
| Q41614336 | Differential effects of cisplatin on the expression of chimeric marker genes in CV-1 cells |
| Q36224281 | Dimethylsulfoxide excerbates cisplatin-induced cytotoxicity in Ehrlich ascites carcinoma cells |
| Q39684689 | Drug resistance and DNA repair |
| Q71044860 | Effect of DNA conformation on cisplatin adduct formation |
| Q91165407 | Evaluation of the protective effects of amifostine and melatonin against cisplatin induced testis injury via oxidative stress and apoptosis in rats |
| Q82297491 | Expressions of Protein Oxidation Markers, Dityrosine and Advanced Oxidation Protein Products in Cisplatin-Induced Nephrotoxicity in Rats |
| Q64390093 | Formation and stability of interstrand cross-links induced by cis- and trans-diamminedichloroplatinum (II) in the DNA of Saccharomyces cerevisiae strains differing in repair capacity |
| Q35593353 | From cisplatin to artificial nucleases--the role of metal ion-nucleic acid interactions in biology |
| Q40504348 | Inactivation of Tetrahymena rRNA self-splicing by cis-platin proceeds through dissociable complexes |
| Q24604428 | Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II) |
| Q34282241 | Mechanisms of resistance to cisplatin |
| Q64033465 | Mono- and bis(9-ethylguanine) complexes of trans-(CH3NH2)2PtII. X-ray structure of the 2:1 complex and redistribution of the 1:1 compound |
| Q24306821 | MutS homologue hMSH5: role in cisplatin-induced DNA damage response |
| Q64033542 | Nucleobase displacement from trans-diamineplatinum(II) complexes. A rationale for the inactivity of trans-DDP as an antitumor agent? |
| Q37621369 | Pharmacological activation of NQO1 increases NAD⁺ levels and attenuates cisplatin-mediated acute kidney injury in mice |
| Q37261476 | Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. |
| Q40677469 | Platinum resistance. Experimental and clinical status. |
| Q41886077 | Recognition of DNA alterations by the mismatch repair system |
| Q40538207 | Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II). |
| Q35936892 | Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts |
| Q39929809 | Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin |
| Q35747835 | Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin |
| Q64033461 | Structural and solution study on binary peptide and ternary peptide–nucleobase complexes of palladium(II) |
| Q32103947 | Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy |
| Q64033470 | Ternary complexes of cisplatin with amino acids and nucleobases. The crystal structure of cis-[(NH3)2Pt(1-MeC-N3)(Gly-N)](NO3)·2H2O |
| Q64033466 | Ternary complexes of trans-Pt(NH3)2Cl2 with amino acids and nucleobases |
| Q37055940 | The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells |
| Q77321343 | The binding affinity of HMG1 protein to DNA modified by cis-platin and its analogs correlates with their antitumor activity |
| Q68292707 | Time- and Sequence-dependent Responses to Cisplatin and Radiation in the Rat Kidney |
| Q43482671 | Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis. |
| Q37449500 | pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma |
Search more.